- Home
- PETZ vs BFRI Comparison
PETZ vs BFRI Comparison
Compare PETZ & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PETZ
- BFRI
- Stock Information
- Founded
- PETZ 2002
- BFRI 1997
- Country
- PETZ China
- BFRI United States
- Employees
- PETZ N/A
- BFRI N/A
- Industry
- PETZ Steel/Iron Ore
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- PETZ Industrials
- BFRI Health Care
- Exchange
- PETZ Nasdaq
- BFRI Nasdaq
- Market Cap
- PETZ 9.3M
- BFRI 7.9M
- IPO Year
- PETZ 2017
- BFRI 2021
- Fundamental
- Price
- PETZ $1.12
- BFRI $0.84
- Analyst Decision
- PETZ
- BFRI Strong Buy
- Analyst Count
- PETZ 0
- BFRI 1
- Target Price
- PETZ N/A
- BFRI $2.75
- AVG Volume (30 Days)
- PETZ 101.4K
- BFRI 367.7K
- Earning Date
- PETZ 04-28-2025
- BFRI 11-12-2025
- Dividend Yield
- PETZ N/A
- BFRI N/A
- EPS Growth
- PETZ N/A
- BFRI N/A
- EPS
- PETZ 0.26
- BFRI N/A
- Revenue
- PETZ $563,726.00
- BFRI $39,188,000.00
- Revenue This Year
- PETZ N/A
- BFRI $11.07
- Revenue Next Year
- PETZ N/A
- BFRI $11.20
- P/E Ratio
- PETZ $5.63
- BFRI N/A
- Revenue Growth
- PETZ 74664.72
- BFRI 11.20
- 52 Week Low
- PETZ $0.65
- BFRI $0.54
- 52 Week High
- PETZ $1.74
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- PETZ 58.29
- BFRI 44.16
- Support Level
- PETZ $1.02
- BFRI $0.81
- Resistance Level
- PETZ $1.20
- BFRI $0.86
- Average True Range (ATR)
- PETZ 0.07
- BFRI 0.05
- MACD
- PETZ 0.01
- BFRI -0.00
- Stochastic Oscillator
- PETZ 53.71
- BFRI 25.00
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.